Nov 5, 2026
Custom Liposomal Resveratrol Powder Solutions for Supplement Brands
A custom liposomal resveratrol powder brief is not a wish list. It is a set of decisions a plant can run, a laboratory can test, and a quality team can release against. Brands that send two lines get a generic quotation back; brands that send a structured brief get a specification they can hand to their own contract manufacturer. The fixed values on the liposomal resveratrol powder platform define exactly what a custom project can and cannot move.
This guide covers the four things a brief has to settle: which variables are adjustable, which are locked, how finished-product requirements become an ingredient specification, and what each project stage should deliver.
What Custom Covers, and What It Does Not
Customization at the ingredient level is narrower than at the formula level. Within one liposomal platform, four levers genuinely move: active load, particle-size and dispersion target, carrier and clean-label position, and protective packaging format. Each changes a process parameter, a raw material or a test method, which is why each has to be justified rather than requested.
Everything else is held constant because it protects the buyer. Trans-resveratrol stays at or above 99% with no cis degradation across stability, encapsulation efficiency stays at or above 85% inside an 85%–92% release window, lead stays below 0.5 ppm, total plate count below 1000 cfu/g, and the shelf-life target is 24 months. A brief asking for 97% trans content at a 70% load is not asking for a custom batch; it is asking for a different molecule. The overview in our complete guide for supplement brands explains where those limits come from.
A supplier who agrees to every line has either not read the brief or expects to renegotiate after the first batch.
| Brief element | What you can change | What stays fixed | How it is verified |
|---|---|---|---|
| Active load | Bands between 10% and 50% | Assay must match the declared band | HPLC, every batch |
| Particle size | Target and polydispersity ceiling agreed per project | Method and reporting basis | DLS, intensity-weighted |
| Dispersion | Powder dispersing in cold water to a translucent colloid | No visible film or sediment | Defined dispersion test |
| Trans isomer | Nothing | ≥99% trans, zero cis degradation | HPLC stability series |
| Encapsulation | Nothing below the floor | ≥85%, release window 85%–92% | Release testing |
| Clean label | Gluten-free and soy-free options | Declared allergen position | Allergen statement |
| Packaging | Barrier format, desiccant, headspace protection | 24-month shelf-life target | Stability, POV by iodometry |
Five Inputs to Settle Before the Specification
Specifications should be derived, not copied. Five finished-product facts determine every number that follows, and a brief that omits any of them forces the supplier to guess.
- Finished format. Two-piece capsule, sachet or stick pack, tablet, gummy, or powder for a ready-to-mix drink.
- Powder mass per serving. The total grams consumed or dissolved, including carriers and flavours.
- Label claim. The resveratrol amount you intend to declare, per serving or per container.
- Process exposure. The highest temperature and longest hold applied after the ingredient is added.
- Shelf life and storage. The months you must support and the conditions you will actually ship and store under.
With those five on one page, the conversation moves from what can you do to here is the band that fits. Load level, dispersion target and packaging protection only make sense read together.
| Input | What it decides | Cost of leaving it blank |
|---|---|---|
| Finished format | Usable load band and powder mass | A band that cannot be filled at all |
| Mass per serving | Minimum active load required | Overage or underage against the claim |
| Label claim | Load calculation and assay target | Release failures at finished-goods testing |
| Process exposure | Carrier selection and drying route | Encapsulation loss during your own process |
| Shelf life and storage | Packaging protection and stability design | A 24-month promise the pack cannot hold |
Turning a Label Claim into a Load Level
The arithmetic is simple and worth doing before you contact anyone. Divide the label claim by the powder mass per serving; the result is the minimum active load the ingredient must carry. Then round up to the nearest band the platform offers between 10% and 50%. Rounding up buys margin for assay variation and for any overage your own testing requires.
Resist the reflex to pick the highest load. A 50% material leaves little room for carriers, so the capsule stays small, but the powder becomes a minor component of the blend and uniformity, flow and segregation get harder to control. A 10%–20% material fills a sachet comfortably and blends easily, at the cost of a larger serving and a stronger carrier taste. Neither is better. Our formulation notes for OEM and ODM teams cover the blending consequences.
| Load band | Formats that fit | Main trade-off |
|---|---|---|
| 10%–20% | Sachets, stick packs, drink mixes | Larger serving mass, carrier taste |
| 25%–35% | Capsules, sachets, gummies | Balanced fill and blend window |
| 40%–50% | Small capsules, compact tablets | Tight blend window, little carrier room |
Writing Particle Size and Dispersion Targets a Lab Can Test
Particle size is the line most often written in a way no laboratory can verify. Small particles is not a specification. State the method, the medium, the temperature, the dilution and the equilibration time, and say whether the target applies to the powder as supplied or to a reconstituted dispersion. DLS returns an intensity-weighted mean with a polydispersity index; both numbers belong in the brief.
The polydispersity index deserves more attention than the mean. Two batches can share a Z-average and behave differently if one carries an aggregation tail, and the tail shows up in dispersion behaviour long before it shows up in the mean. Set a ceiling on PDI and read upward drift as a process signal rather than a release formality. TEM is used for morphology, not sizing, so it should not become a release limit.
Dispersion language needs the same discipline. Disperses easily cannot be checked. Specify the water temperature, the ratio of powder to water, the agitation you will use, and what acceptable looks like — here, a translucent colloid without visible film or sediment. Our notes on resveratrol solubility in liposomal systems explain why the carrier and the drying step, not the mixing step, usually decide this outcome.
Clean Label and Certification as Requirements
Certification statements belong in the brief as requirements, not assumptions. This platform is manufactured under cGMP with ISO 9001 and ISO 22000, and holds Kosher, Halal, Non-GMO and Vegan status. Gluten-free and soy-free are offered as clean-label options, and they are options for a reason: the phospholipid source and the carrier system have to be selected and qualified for them. A brief that adds soy-free on the last page has wasted a trial batch.
Say which certificates you need as documents, not logos on a label. Request the allergen statement, the non-GMO statement and the certificate scope, then check that the scope covers the manufacturing site rather than a trading entity. If the finished product will carry a claim, confirm in writing that the ingredient documentation supports the wording.
Packaging and Protection as Brief Items
Powder stability is decided as much by what happens after release as in the dryer: moisture pickup, light, headspace oxygen and repeated opening all act on the same phospholipid matrix. Describe the warehouse, the transit route and how often a container is opened on the filling line, then translate that into a packaging request rather than a brand name. Barrier format, desiccant where the climate requires it, and headspace protection are the three levers. Tie them to evidence: the 24-month target, moisture at release and on stability, appearance, and peroxide value by iodometric titration as the oxidative marker. If you intend to repack, say so — a repack is a new exposure event.
A powder specified for cold-water dispersion is usually right for a stick pack and wrong for a tablet press, and the reverse also holds. If one ingredient has to serve two formats, say that at the start; the compromise is a specification decision, not a production detail. Comparing powder and liquid formats first saves a round of correspondence.
Three Stages, Three Sets of Deliverables
Custom projects move through feasibility, pilot and scale-up, and each stage should end with a document rather than a phone call. In feasibility, expect a technical response to your brief, a trial batch and a preliminary certificate of analysis. The purpose is to confirm that your target sits inside platform capability, and to say plainly when it does not.
The pilot stage produces the full release package: assay by HPLC, particle size and PDI by DLS, morphology by TEM, peroxide value, lead, total plate count, moisture and appearance. It should also include a dispersion trial in your own matrix, because a powder that behaves in water may not behave in a flavoured drink mix. Stability is initiated here, not later.
Scale-up is where the brief becomes a contract. Ask for the critical process parameters, the hold points, and a written change-control clause: what triggers notification, how much notice is given, and what gets re-validated when a raw material source or a drying condition changes. A supplier who cannot describe change control is describing a batch, not a supply relationship. The same questions appear in our guide to choosing a trustworthy resveratrol powder supplier.
What Stays on the Brand's Side
An ingredient specification is not a finished-product specification, and a certificate of analysis does not transfer responsibility. Claim wording, regulatory classification in each market, finished-goods stability and label declarations remain with the brand. Supplier documentation supports those decisions; it does not make them.
The split matters most at the boundary. In the United States, structure and function wording sits under FDA labelling rules; in the European Union, claim wording is governed by the health claims regulation and its authorised list. Neither framework cares that the ingredient is liposomal. Category expectations are moving too, which is why the outlook for liposomal resveratrol in functional food is worth reading alongside the specification.
Review the Brief Before You Send It
A brief that survives ten minutes of self-review usually saves two weeks of correspondence.
- Every number has a unit, a method and a test condition attached.
- The load band is derived from the claim and the serving mass, not chosen by preference.
- Fixed items are stated as fixed, not as opening positions to negotiate.
- Clean-label and certification requirements appear on page one.
- Storage, transit and repacking are described as they will actually happen.
- One named person owns approvals on your side.
If a line cannot be tested by a third-party laboratory, it is not a specification yet. Our checklist for evaluating a liposomal resveratrol ingredient covers the evidence side, and the bulk supply overview explains what changes when volumes grow. Blends raise their own questions, and combining resveratrol with other actives is a sensible next read if your formula has more than one ingredient.
Send a Brief We Can Answer in One Round
EmerWell supplies liposomal resveratrol powder from San Diego with a documented release package and a specification that can be tailored within the limits described above. Send your five inputs — finished format, powder mass per serving, label claim, process exposure and shelf life — to info@emerwell-bio.com, and we will return a feasibility response with a draft specification, the current certificate of analysis and a sample for your own dispersion and stability work.
Current release values are published on the resveratrol product page.
References
- U.S. Food and Drug Administration. 21 CFR Part 111 — Current Good Manufacturing Practice for Dietary Supplements.
- U.S. Food and Drug Administration. Dietary Supplements Guidance Documents and Regulatory Information.
- European Food Safety Authority. Health Claims — EU regulatory framework and authorised list.
- United States Pharmacopeia. USP–NF General Chapters.
This article is written for formulators, quality and procurement professionals as technical information about supplement ingredients. It is not medical or nutritional advice and does not describe any finished-product claim.
Online Message